Author

S.J. Lee

Observed names: SungJeong Lee, Sungjeong Lee

Institution: Celltrion (South Korea)

Observed institution: Celltrion (South Korea)

ORCID: 0000-0003-3974-7999

Observed ORCID: 0000-0003-3974-7999

OpenAlex ID: A5086300577

DOP061 Phase III randomised, double-blind, controlled trial to compare biosimilar infliximab (CT-P13) with innovator infliximab in patients with active Crohn's disease: early efficacy and safety results

2017 · Y.H. Kim, B.D. Ye, et al. · Journal of Crohn s and Colitis · 19

THU0191 Novel formulation of ct-p13 for subcutaneous administration in patients with rheumatoid arthritis: initial results from a phase i/iii randomised controlled trial

2018 · R. Westhovens, D.H. Yoo, et al. · Annals of the Rheumatic Diseases · 17

Double-blind, randomized phase III study to compare the efficacy and safety of trastuzumab and its biosimilar candidate CT-P6 in HER2 positive early breast cancer (EBC)

2017 · F.J. Esteva, Y. Baranau, et al. · Annals of Oncology · 7

3-year follow-up of a phase III trial comparing the efficacy and safety of neoadjuvant and adjuvant trastuzumab and its biosimilar CT-P6 in HER2 positive early breast cancer (EBC)

2019 · J. Stebbing, Y. Baranau, et al. · Annals of Oncology · 4

AB0433 Meta-Analysis of the Safety Data Between Infliximab Biosimilar (CT-P13) and Innovator Infliximab in Rheumatoid Arthritis and Ankylosing Spondylitis

2015 · W. Park, D.H. Yoo, et al. · Annals of the Rheumatic Diseases · 3

CT-P10 versus reference rituximab in combination with CVP in advanced-stage follicular lymphoma: Phase 3, double-blind, randomized trial

2017 · W.S. Kim, B. Coiffier, et al. · Annals of Oncology · 2

P487 Effectiveness and safety of CT-P13 under routine care in paediatric patients with inflammatory bowel disease

2017 · Y.H. Choe, H.R. Yang, et al. · Journal of Crohn s and Colitis · 2

P500 Effectiveness and safety in Crohn's disease patients who were treated with CT-P13

2017 · Y.H. Choe, S.-H. Lee, et al. · Journal of Crohn s and Colitis · 2

CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability Study

2025 · David M. Pariser, Mark G. Lebwohl, et al. · Dermatology and Therapy · 1

Hypothesis testing in Cox models when continuous covariates are dichotomized: bias analysis and bootstrap-based test

2024 · Hyunman Sim, Sungjeong Lee, et al. · Computational Statistics

185P Long-term efficacy of trastuzumab biosimilar CT-P6 in patients with HER2-positive early breast cancer: 6-year survival analysis of phase III study results

2022 · J. Stebbing, Y. Baranau, et al. · Annals of Oncology

Works count: 11

Citation count: 57

H-index: 4

I10-index: 2